Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-14

Clinical Trial Update: Amiloride in Nephrotic Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating amiloride for nephrotic syndrome was terminated, and the results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amiloride (amiloride)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Nephrotic Syndrome, Edema | Phase 3 | Status: TERMINATED | Results posted: 2025-01-14